Medical Dialogues

FDA Approves First Treatment for HSCT-Associated Thrombotic Microangiopathy

The U.S. FDA has approved narsoplimab (Yartemlea) as the first indicated therapy for hematopoietic stem cell transplant–associated thrombotic microangiopathy (TA-TMA) in adults and children aged ...

FDA Approves Omeros' YARTEMLEA(R) -- First and Only Therapy Indicated for TA-TMA

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

FDA Approves Omeros' First-In-Class Drug For Rare Transplant Complication

The U.S. Food and Drug Administration (FDA) on Wednesday approved Omeros Corporation (NASDAQ: OMER) Yartemlea ...
Le Lézard

FDA Approves Omeros' YARTEMLEA® ? First and Only Therapy Indicated for TA-TMA

Omeros Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® (narsoplimab-wuug) for the treatment of hematopoietic stem cell transplant-associated ...

Changing the paradigm on hypermobile Ehlers-Danlos syndrome: Connective tissues don't tell the whole story

Recent research from the Medical University of South Carolina laboratory of Russell Norris, Ph.D., challenges the notion that ...

Paroxysmal Nocturnal Hemoglobinuria Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | Alexion Pharma, Hoffmann-La Roche, Novartis, Regeneron ...

In 2023, Japan's market size for Paroxysmal Nocturnal Hemoglobinuria therapeutics was around USD 88.5 million, with expectations of growth throughout the forecast period (2024-2034). Projections ...

Study reveals dietary nutrient that can produce diabetes-fighting chemical in gut

Scientists have identified a gut microbe molecule, trimethylamine (TMA), that shows promise in controlling blood sugar and combating insulin resistance. This discovery offers a new direction for ...

Recordati Rare Diseases Announces Real-World Data on Long-Term Safety of ENJAYMO(R) (sutimlimab-jome) in Cold Agglutinin Disease and Cold Agglutinin Syndrome (CAD/CAS) at ...

Recordati Rare Diseases Inc. today announced the presentation of real-world data that build upon the safety data of sutimlimab, an FDA-approved therapy for hemolysis in adults with cold agglutinin ...
9NEWS

Alternative pathways helping Douglas County Schools fill jobs as Colorado seeks to curb teacher shortage

LONE TREE, Colo. — As fewer people go to school to be teachers and many leave the profession altogether, school districts are turning to alternative pathways to bring new teachers into classrooms. "I ...
Becker's Hospital Review

Another state offers alternative licensure pathway for foreign physicians

Texas will become the 13th state to offer an alternative licensure pathway for experienced international physicians this September, The Dallas Morning News reported Aug. 13. House Bill 2038 — called ...

5 Ways Turmeric Can Benefit Your Health, From Easing Pain to Reducing Inflammation

Dietitians and herbalists share how the herb can help joint paint and inflammation, and how much you should take to make a ...
The American Journal of Managed Care

iAMD Progression Linked to Dysregulation of Complement Pathways

Dysregulated complement pathways are linked to progression from iAMD to advanced AMD, including NVAMD and GA. Higher systemic levels of C4, C4b, and a reduction in C3 are associated with increased ...